Nigel Dimmock - Publications

1971- Biological Sciences University of Warwick, Coventry, England, United Kingdom 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Meng B, Bentley K, Marriott AC, Scott PD, Dimmock NJ, Easton AJ. Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA. Virology Journal. 14: 138. PMID 28738877 DOI: 10.1186/s12985-017-0805-6  0.336
2016 Smith CM, Scott PD, O'Callaghan C, Easton AJ, Dimmock NJ. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral. Viruses. 8. PMID 27556481 DOI: 10.3390/v8080237  0.359
2014 Marriott AC, Dove BK, Whittaker CJ, Bruce C, Ryan KA, Bean TJ, Rayner E, Pearson G, Taylor I, Dowall S, Plank J, Newman E, Barclay WS, Dimmock NJ, Easton AJ, et al. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. Plos One. 9: e94090. PMID 24709834 DOI: 10.1371/journal.pone.0094090  0.347
2014 Dimmock NJ, Easton AJ. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals? Journal of Virology. 88: 5217-27. PMID 24574404 DOI: 10.1128/JVI.03193-13  0.39
2012 Dimmock NJ, Dove BK, Scott PD, Meng B, Taylor I, Cheung L, Hallis B, Marriott AC, Carroll MW, Easton AJ. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. Plos One. 7: e49394. PMID 23251341 DOI: 10.1371/journal.pone.0049394  0.364
2012 Dimmock NJ, Dove BK, Meng B, Scott PD, Taylor I, Cheung L, Hallis B, Marriott AC, Carroll MW, Easton AJ. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Research. 96: 376-85. PMID 23041142 DOI: 10.1016/j.antiviral.2012.09.017  0.358
2011 Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Vaccine. 29: 6584-91. PMID 21762748 DOI: 10.1016/j.vaccine.2011.06.114  0.328
2011 Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. The Journal of General Virology. 92: 2122-32. PMID 21632569 DOI: 10.1099/vir.0.034132-0  0.326
2008 Dimmock NJ, Rainsford EW, Scott PD, Marriott AC. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. Journal of Virology. 82: 8570-8. PMID 18579602 DOI: 10.1128/JVI.00743-08  0.322
2006 Dimmock NJ, Marriott AC. In vivo antiviral activity: Defective interfering virus protects better against virulent Influenza A virus than avirulent virus Journal of General Virology. 87: 1259-1265. PMID 16603528 DOI: 10.1099/vir.0.81678-0  0.352
2004 Noble S, McLain L, Dimmock NJ. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Vaccine. 22: 3018-25. PMID 15297051 DOI: 10.1016/j.vaccine.2004.02.013  0.311
2003 Reading SA, Heap CJ, Dimmock NJ. A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny. Virology. 315: 362-72. PMID 14585339  0.303
Show low-probability matches.